Clinical Trial Update: The VERIFY Study: An Observational Study Called VERIFY to Learn More About the Use of Vericiguat in People With Chronic Heart Failure With Reduced Ejection Fraction

View source ↗

Summary

The VERIFY study is an observational trial by Bayer to learn more about the use of vericiguat in people with chronic heart failure with reduced ejection fractio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• Verquvo (vericiguat)

Snippet

Sponsor: Bayer | Conditions: Chronic Heart Failure With Reduced Ejection Fraction | Status: COMPLETED